Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Celmatix identifies AMHR2 agonist to prevent premature menopause after chemotherapy

May 16, 2022

VERVE-101 shows durable editing of PCSK9 gene; GalNAc-LNPs improve delivery of base editors

May 13, 2022

Aro's Centyrin-targeted siRNA conjugates show potential for Pompe disease

May 12, 2022

GT-02329 shows promise in in vitro and in vivo Gaucher disease models

May 12, 2022

NexImmune, Yale and JDRF partner to explore AIM nanoparticles with teplizumab for type 1 diabetes

May 11, 2022

Type 2 diabetes getting precision medicine makeover

May 11, 2022

Comparative study focuses lens of human reproductive aging

May 10, 2022

Hangzhou Zhongmei Huadong Pharmaceutical divulges GLP-1 receptor agonists

May 10, 2022

Gasherbrum Bio identifies new GLP-1 receptor agonists

May 9, 2022

Gannex Pharma presents new FXR agonists

May 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...